Correction: Current advances in gene therapy of mitochondrial diseases

J Transl Med. 2023 Feb 8;21(1):96. doi: 10.1186/s12967-023-03915-z.

Vladislav O Soldatov^{1

2

3}, Marina V Kubekina⁴, Marina Yu Skorkina^{5

6}, Andrei E Belykh⁷, Tatiana V Egorova⁸, Mikhail V Korokin⁹, Mikhail V Pokrovskiy⁹, Alexey V Deykin^{9

6}, Plamena R Angelova¹⁰

¹ Core Facility Centre, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia. pharmsoldatov@gmail.com.
² Department of Pharmacology and Clinical Pharmacology, Belgorod State National Research University, Belgorod, Russia. pharmsoldatov@gmail.com.
³ Laboratory of Genome Editing for Biomedicine and Animal Health, Belgorod State National Research University, Belgorod, Russia. pharmsoldatov@gmail.com.
⁴ Core Facility Centre, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
⁵ Department of Biochemistry, Belgorod State National Research University, Belgorod, Russia.
⁶ Laboratory of Genome Editing for Biomedicine and Animal Health, Belgorod State National Research University, Belgorod, Russia.
⁷ Dioscuri Centre for Metabolic Diseases, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
⁸ Laboratory of Modeling and Gene Therapy of Hereditary Diseases, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
⁹ Department of Pharmacology and Clinical Pharmacology, Belgorod State National Research University, Belgorod, Russia.
¹⁰ Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.

No abstract available

Publication types